Zeria Pharmaceutical Co. Ltd. | Cash Flow
Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
2019
Net Income before Extraordinaries
7,309
3,820
5,262
4,921
5,577
5,221
Depreciation, Depletion & Amortization
2,625
2,706
3,119
3,795
3,840
3,734
Other Funds
-
-
-
592
7
1,445
Funds from Operations
6,922
3,310
6,034
7,757
8,315
7,510
Changes in Working Capital
349
2,656
340
518
507
2,009
Net Operating Cash Flow
6,573
653
5,695
7,238
8,822
5,501
Capital Expenditures
3,193
1,877
28,948
3,722
2,043
Sale of Fixed Assets & Businesses
1,149
-
-
-
-
Purchase/Sale of Investments
1,389
2,466
2,633
2,995
3,884
Net Investing Cash Flow
2,014
476
32,709
703
1,564
Cash Dividends Paid - Total
1,152
1,586
1,587
1,694
1,711
Issuance/Reduction of Debt, Net
4,455
4,252
24,004
6,695
2,303
Net Financing Cash Flow
9,001
5,840
22,416
8,983
9,629
Net Change in Cash
14,835
4,533
5,669
3,092
916
Free Cash Flow
3,625
1,140
3,360
5,566
7,037
Net Assets from Acquisitions
911
-
1,077
-
-
Other Sources
91
11
41
44
38
Change in Capital Stock
14,609
1
1
1
5,608
Exchange Rate Effect
1,274
177
1,071
645
159
Other Uses
539
123
92
19
315
About Zeria Pharmaceutical Co.
View Profile
